发明名称 Modulators of cannabinoid receptors
摘要 The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof, wherein Z is OR 1 or NR 1 R 2 wherein each of R 1 and R 2 is independently H, or a hydrocarbyl group;X is an alkylene, alkenylene, or alkynylene group, each of which may be optionally substituted by one or more substituents selected from alkyl, COOH, CO 2 -alkyl, alkenyl, CN, NH 2 , hydroxy, halo, alkoxy, CF 3 and nitro; Y is a polar functional group selected from OH, NO 2 CN, COR 3 , COOR 3 , NR 3 R 4 , CONR 3 R 4 , SO 3 H, SO 2 -R 3 , SO 2 NR 3 R 4 and CF 3 , where each of R 3 and R 4 is independently H or a hydrocarbyl group; A is an aryl or heteroaryl group, each of which may be optionally substituted; and B is (CH 2 ) n where n is 0, 1, 2, 3, 4 or 5; with the proviso that: (i) when A is phenyl, n is 0, and Z is OH, X-Y is other than meta -C‰¡C-(CH 2 ) 2 CO 2 H, meta -C‰¡C-(CH 2 ) 2 OH, meta -C‰¡C-(CH 2 ) 2 CO 2 Me, meta- (CH 2 ) 4 CO 2 H, ortho -CH 2 CO 2 H, ortho -(CH 2 ) 2 CO 2 H and ortho -(CH 2 ) 4 CO 2 H; and (ii) when A is phenyl, n is 0, and Z is OMe, X-Y is other than meta -C‰¡C-(CH 2 ) 4 OH. Further aspects of the invention relate to the use of such compounds in the preparation of a medicament for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors.
申请公布号 AU2005214146(A1) 申请公布日期 2005.09.01
申请号 AU20050214146 申请日期 2005.02.21
申请人 UCL BIOMEDICA PLC. 发明人 DAVID BAKER;DAVID SELWOOD;MASAHIRO OKUYAMA;CRISTINA VISINTIN;GARETH PRYCE
分类号 C07C233/68;C07C63/04;C07C69/76;C07C69/78;C07C233/11;C07C233/65;C07C233/66;C07C233/69;C07C233/77;C07C235/42;C07C235/78;C07C235/84;C07C237/32;C07C237/38;C07C237/42;C07C255/41 主分类号 C07C233/68
代理机构 代理人
主权项
地址